Regulatory Focus™ > News Articles > FDA Approves New HIV Treatment

FDA Approves New HIV Treatment

Posted 28 August 2012

The U.S. Food and Drug Administration (FDA) approved a new combination pill to treat HIV-1 infection in adults, according to an agency press release.

The new pill, called Stribild, contains two new drugs combined with two previously approved drugs. The statement said these drugs together provide a complete treatment plan for HIV infection.

"Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens," said Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products, in the release. "New combination HIV drugs like Stribild help simplify treatment regimens."

FDA has also approved other drugs and tests in the treatment of HIV/AIDS, including the first over-the-counter home-use rapid HIV test. Gilead Sciences, maker of Stribild, will continue to test the drug's safety in women and children, and possible interactions between it and other drugs, according to the statement.

Read more

• "FDA approves new combination pill for HIV treatment for some patients" - FDA News Release

Regulatory Focus newsletters

All the biggest regulatory news and happenings.